Bromide

Bromide

SCHEMBL7758538

Br.[O-][n+]1ccnc2ccccc21

nearest known ligand 0.37

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.37
ATM Q13315 1/20 0.35
NCF1 P14598 1/20 0.32
TSHR P16473 1/20 0.31
CRHBP P24387 1/20 0.31
CRHR2 Q13324 1/20 0.31
KEAP1 Q14145 1/20 0.31
NFE2L2 Q16236 1/20 0.31
LOXL2 Q9Y4K0 1/20 0.31
LMNA P02545 1/20 0.30
HTT P42858 1/20 0.30
HSD17B10 Q99714 1/20 0.30
KDM4E B2RXH2 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL240893 0.98 ALDH1A1 (0.38) ALDH1A1ATMNCF1TSHRCRHBP
Quinoxaline SCHEMBL5268892 0.94 ALDH1A1 (0.35) ALDH1A1ATMNCF1TSHRCRHBP
SCHEMBL29364156 0.83 ALDH1A1 (0.41) ALDH1A1ATMTSHRLMNAHTT
SCHEMBL247478 0.83 ALDH1A1 (0.41) ALDH1A1ATMTSHRLMNAHTT
SCHEMBL5894630 0.73 METAP1 (0.32)
SCHEMBL1747903 0.73 KDM4A (0.31)
SCHEMBL1015423 0.72 NUDT1 (0.31) TSHRLMNAHTTKDM4E
SCHEMBL9317055 0.72 ALDH1A1 (0.38) ALDH1A1NCF1TSHR
Quinoline SCHEMBL28190534 0.72 ALDH1A1 (0.59) ALDH1A1ATMTSHRLMNAHTT
SCHEMBL5894455 0.71 ALDH1A1 (0.41) ALDH1A1ATMTSHRLMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0620732-B1 METHODS FOR USING (2-IMIDAZOLIN-2-YLAMINO) QUINOXALINE DERIVATIVES ALLERGAN INC (US) 2001-04-04 EP disclosed
EP-0549594-B1 (2-IMIDAZOLIN-2-YLAMINO) QUINOXALINE DERIVATIVES AND METHODS FOR USING SAME ALLERGAN INC (US) 1995-02-01 EP disclosed